— Know what they know.
Not Investment Advice

FBLG Dividends

FibroBiologics, Inc. Common Stock
1W: +1.3% 1M: -31.5% 3M: +42.3% YTD: -80.6% 1Y: -89.3%
$0.93
-0.01 (-0.87%)
 
Weekly Expected Move ±10.0%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 27 · $6.2M mcap · 5M float · 3.78% daily turnover · Short 43% of daily vol
Credit Risk of going bust: higher than 92% of companies Debt: 18.9% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.05 (down 95%), FibroBiologics, Inc. Common Stock would be worth roughly what it owes.
Total debt $1.5M against a stock market value of $6.3M.
Distance to default 1.22 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $664K (short-term plus half of long-term), stock volatility 139.3%; Altman Z'' -36.66. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
FBLG does not currently pay a dividend.
This company has no dividend payment history on record.
Stock Split History (1 splits)
DateRatioType
2026-03-30 1:20 stock-split

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms